Literature DB >> 19270088

Characterization of the Streptococcus pneumoniae BgaC protein as a novel surface beta-galactosidase with specific hydrolysis activity for the Galbeta1-3GlcNAc moiety of oligosaccharides.

Jae Kap Jeong1, Ohsuk Kwon, Yun Mi Lee, Doo-Byoung Oh, Jung Mi Lee, Seonghun Kim, Eun-Hye Kim, Tu Nhat Le, Dong-Kwon Rhee, Hyun Ah Kang.   

Abstract

Streptococcus pneumoniae is a causative agent of high morbidity and mortality. Although sugar moieties have been recognized as ligands for initial contact with the host, only a few exoglycosidases have been reported to occur in S. pneumoniae. In this study, a putative beta-galactosidase, encoded by the bgaC gene of S. pneumoniae, was characterized for its enzymatic activity and virulence. The recombinant BgaC protein, expressed and purified from Escherichia coli, was found to have a highly regiospecific and sugar-specific hydrolysis activity for the Galbeta1-3-GlcNAc moiety of oligosaccharides. Interestingly, the BgaC hydrolysis activity was localized at the cell surface of S. pneumoniae, indicating that BgaC is expressed as a surface protein although it does not have a typical signal sequence or membrane anchorage motif. The surface localization of BgaC was further supported by immunofluorescence microscopy analysis using an antibody raised against BgaC and by a reassociation assay with fluorescein isothiocyanate-labeled BgaC. Although the bgaC deletion mutation did not significantly attenuate the virulence of S. pneumoniae in vivo, the bgaC mutant strain showed relatively low numbers of viable cells compared to the wild type after 24 h of infection in vivo, whereas the mutant showed higher colonization levels at 6 and 24 h postinfection in vivo. Our data strongly indicate for the first time that S. pneumoniae bgaC encodes a surface beta-galactosidase with high substrate specificity that is significantly associated with the infection activity of pneumococci.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270088      PMCID: PMC2681812          DOI: 10.1128/JB.01601-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

1.  Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors.

Authors:  Gursharan S Chhatwal
Journal:  Trends Microbiol       Date:  2002-05       Impact factor: 17.079

2.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

3.  Cloning and characterization of the gene encoding a novel beta-galactosidase from Bacillus circulans.

Authors:  Y Ito; T Sasaki
Journal:  Biosci Biotechnol Biochem       Date:  1997-08       Impact factor: 2.043

Review 4.  A novel approach to antiviral therapy for influenza.

Authors:  P M Colman
Journal:  J Antimicrob Chemother       Date:  1999-11       Impact factor: 5.790

5.  Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium.

Authors:  H H Tong; M A McIver; L M Fisher; T F DeMaria
Journal:  Microb Pathog       Date:  1999-02       Impact factor: 3.738

6.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

7.  Modulation of adherence, invasion, and tumor necrosis factor alpha secretion during the early stages of infection by Streptococcus pneumoniae ClpL.

Authors:  Le Nhat Tu; Hye-Yoon Jeong; Hyog-Young Kwon; Abiodun D Ogunniyi; James C Paton; Suhk-Neung Pyo; Dong-Kwon Rhee
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

8.  Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae.

Authors:  J N Weiser; D Bae; H Epino; S B Gordon; M Kapoor; L A Zenewicz; M Shchepetov
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Interaction of divalent cations with beta-galactosidase (Escherichia coli).

Authors:  R E Huber; C Parfett; H Woulfe-Flanagan; D J Thompson
Journal:  Biochemistry       Date:  1979-09-18       Impact factor: 3.162

10.  Sequence of the Kluyveromyces lactis beta-galactosidase: comparison with prokaryotic enzymes and secondary structure analysis.

Authors:  O Poch; H L'Hôte; V Dallery; F Debeaux; R Fleer; R Sodoyer
Journal:  Gene       Date:  1992-09-01       Impact factor: 3.688

View more
  25 in total

1.  Structural insights into the substrate specificity of Streptococcus pneumoniae β(1,3)-galactosidase BgaC.

Authors:  Wang Cheng; Lei Wang; Yong-Liang Jiang; Xiao-Hui Bai; Jun Chu; Qiong Li; Ge Yu; Qiu-Ling Liang; Cong-Zhao Zhou; Yuxing Chen
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  A novel cold-adapted β-galactosidase isolated from Halomonas sp. S62: gene cloning, purification and enzymatic characterization.

Authors:  Guo-Xiang Wang; Yun Gao; Bo Hu; Xiao-Ling Lu; Xiao-Yu Liu; Bing-Hua Jiao
Journal:  World J Microbiol Biotechnol       Date:  2013-03-14       Impact factor: 3.312

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  Utilization of lactose and galactose by Streptococcus mutans: transport, toxicity, and carbon catabolite repression.

Authors:  Lin Zeng; Satarupa Das; Robert A Burne
Journal:  J Bacteriol       Date:  2010-02-26       Impact factor: 3.490

5.  SP0454, a putative threonine dehydratase, is required for pneumococcal virulence in mice.

Authors:  WenJuan Yan; Hong Wang; WenChun Xu; KaiFeng Wu; Run Yao; XiuYu Xu; Jie Dong; YanQing Zhang; Wen Zhong; XueMei Zhang
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

Review 6.  Composition and development of oral bacterial communities.

Authors:  Robert J Palmer
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

7.  Cloning, purification and biochemical characterisation of a GH35 beta-1,3/beta-1,6-galactosidase from the mucin-degrading gut bacterium Akkermansia muciniphila.

Authors:  Bi-Shan Guo; Feng Zheng; Lucy Crouch; Zhi-Peng Cai; Meng Wang; David N Bolam; Li Liu; Josef Voglmeir
Journal:  Glycoconj J       Date:  2018-05-12       Impact factor: 2.916

8.  The β-galactosidase (BgaC) of the zoonotic pathogen Streptococcus suis is a surface protein without the involvement of bacterial virulence.

Authors:  Dan Hu; Fengyu Zhang; Huimin Zhang; Lina Hao; Xiufang Gong; Meiling Geng; Min Cao; Feng Zheng; Jin Zhu; Xiuzhen Pan; Jiaqi Tang; Youjun Feng; Changjun Wang
Journal:  Sci Rep       Date:  2014-02-21       Impact factor: 4.379

9.  Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae.

Authors:  Vanessa S Terra; Karen A Homer; Susmitha G Rao; Peter W Andrew; Hasan Yesilkaya
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

10.  Cloning, expression, and characterization of a peculiar choline-binding beta-galactosidase from Streptococcus mitis.

Authors:  Susana Campuzano; Beatriz Serra; Daniel Llull; José L García; Pedro García
Journal:  Appl Environ Microbiol       Date:  2009-07-24       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.